Related Experiment Video
Updated: Oct 4, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review
Jean de Dieu Habimana1, Rongqi Huang1, Bertrand Muhoza2
1Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, 19 Yuquan Road, Shijingshan District, Beijing, 100049, China.
Abstract:
Conventional and routine diagnostics such as polymerase chain reaction (PCR) and serological tests are less sensitive, costly, and require sample pretreatment procedures. CRISPR/Cas systems that inherently assist bacteria and archaea in destroying invading phage genetic materials via an RNA-mediated interference strategy have been reconstituted in vitro and harnessed for nucleic and non-nucleic acid diagnostics. CRISPR/Cas-based diagnostics (CRISPR-Dx) are cost-effective, possess excellent sensitivity (attomolar) and specificity (single base distinction), exhibit fast turnaround response, and support nucleic acid extraction-free workflow. However, CRISPR-Dx still needs to address various challenges to translate the laboratory work into end-user tailored solutions. In this perspective, we review the relevant progress of CRISPR/Cas systems-based diagnostics, focusing on the comprehensive customization and applications of leading and trending CRISPR/Cas systems as platform technologies for fluorescence, colorimetric, and electrical signal detection. The impact of the CRISPR game-changing technology on the COVID-19 pandemic is highlighted. We also demonstrate the role of CRISPR/Cas systems for carryover contamination prevention. The advancements in signal amplification strategies using engineered crRNAs, novel reporters, nanoparticles, artificial genetic circuits, microfluidics, and smartphones are also covered. Furthermore, we critically discuss the translation of CRISPR-Dx's basic research into end-user diagnostics for commercialization success in the near future. Finally, we discuss the complex challenges and alternative solutions to harness the CRISPR/Cas potential in detail.
Insights
CRISPR-based diagnostics offer a cost-effective, highly sensitive alternative to traditional methods. This review explores CRISPR/Cas systems
Area of Science:
- Molecular Biology
- Biotechnology
- Diagnostic Technologies
Background:
- Conventional diagnostics like PCR and serology have limitations in sensitivity, cost, and workflow.
- CRISPR/Cas systems, naturally occurring bacterial defense mechanisms, have been repurposed for in vitro diagnostics.
- CRISPR-based diagnostics (CRISPR-Dx) offer potential advantages over existing methods.
Purpose of the Study:
- To review the advancements in CRISPR/Cas systems for diagnostic applications.
- To focus on the customization and application of CRISPR/Cas systems for various signal detections.
- To discuss challenges and strategies for translating CRISPR-Dx from research to commercialization.
Main Methods:
- Review of literature on CRISPR/Cas systems and their diagnostic applications.
- Focus on leading and trending CRISPR/Cas systems for fluorescence, colorimetric, and electrical detection.
- Analysis of signal amplification strategies, including engineered crRNAs, reporters, nanoparticles, and microfluidics.
Main Results:
- CRISPR-Dx exhibits high sensitivity (attomolar), specificity (single base distinction), and cost-effectiveness.
- CRISPR/Cas systems have demonstrated impact in areas like COVID-19 diagnostics and contamination prevention.
- Advancements in signal amplification and integration with technologies like smartphones enhance CRISPR-Dx capabilities.
Conclusions:
- CRISPR/Cas systems represent a transformative technology for next-generation diagnostics.
- Addressing challenges in customization, signal detection, and commercialization is crucial for widespread adoption.
- Further research and development are needed to fully harness the potential of CRISPR-Dx for end-user solutions.
More Related Videos
08:20A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
The Antiviral System of Bacteria and Archaea: CRISPR